Identification of Novel Immune-associated Gene Signature for Diagnosis and Survival Prediction in Ch

来源 :2019中国肿瘤学大会 | 被引量 : 0次 | 上传用户:liongliong550
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective This study aimed to identify reliable and distinct immune-associated gene signatures for robust classification and survival prediction of patients with CLL.
其他文献
目的 目的:鉴定和分离肿瘤干细胞最常应用的方法是依据细胞表面标志物,利用流式细胞术进行分选。目前,CD44/CD24与乙醛脱氢酶1(ALDH1)都是公认的乳腺癌干细胞标志物,但是两种标志物之间的关系,以及利用这两种标志物分离出的细胞亚群之间的关系都有待阐明。
目的 Isotope labeled relative and absolute quantification(iTRAQ)technology was adopted to screen serum differentially expressed proteins that predict the effect of radiochemotherapy for esophageal squam
Objective Background:Emerging evidence suggests that cancer stem cells(CSCs),a minor population of cancer cells that display profound chemoradiotherapy resistance,play a critical role in tumor initiat
目的 分析黑素瘤与色素痣的差异表达基因,从转录组水平揭示黑素瘤的发病机制。方法 本研究中选用4 例黑素瘤患者肿瘤组织和3 例色素痣患者色素痣组织样本,提取RNA 后用Illumina 测序平台进行高通量测序并进行分析,得到差异表达基因后,对差异表达基因进行相关的功能聚类及相互作用分析。
Objective Myeloid-derived suppressor cells(MDSCs)contribute to tumor-mediated immune escape and negatively correlate with overall survival of cancer patients.
目的 上皮性卵巢癌是最致命的妇科肿瘤之一,卵巢癌患者预后差,通常在2 年内复发。因此,建立一个能预测上皮性卵巢癌预后情况的体系具有重要意义。方法 为了研究代谢物是否可用于预测卵巢癌的预后情况,我们对98 份卵巢癌患者的血浆样本进行了代谢组学分析,本研究分别采用超高效液相色谱-质谱(UPLC/MS)联用技术中阳离子(ESI+)和阴离子(ESI-)模式进行检测。
Objective Beta-thalassemia(β-thalassemia)is characterized by abnormalities in the synthesis of the hemoglobin subunit beta(hemoglobin beta chain),resulting in anemia of different degrees of severity1.
Objective AML(acute myeloid leukemia))originates from the abnormal clonal proliferation of myeloblast which often combined with clinical symptoms such as infection,fever,hemorrhage and anemia.
Objective Immunotherapy by targeting the PD-1/PD-L1 receptor in melanoma patients has achieved a great success.Although many studies have addressed the underlying mechanisms involved in blockade of PD
Objective Ewing sarcoma(ES)is a second-most-common malignant pediatric tumor from bone and soft tissue with high metastatic incidence,and it occurs at any age with a peak during 10-20 years old.